Startups
Learn about LUCENTIS (ranibizumab injection), a treatment option for wet AMD, diabetic macular edema (DME), diabetic retinopathy (DR), mCNV, & RVO. See full safety for more information.
Overview
Employees
11-50
Mentions in press and media 5
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Nov 4, 2013 | Healthcare startup with noninvasive, one-time wet AMD treatment touts two years of success | Anti-VEGF therapy proved to be a major breakthrough in treatment for wet AMD. The drugs could halt the progression of the disease and even recapture some lost vision, Taylor said. But the drugs are a chronic therapy. “The patient should go ... |
| Jul 25, 2007 | Aptamer-drug maker Archemix files for $69M IPO | (UPDATED: See below.) Archemix, a Cambridge, Mass., biotech developing drugs out of nucleic-acid chains called aptamers, filed to raise as much as $69 million in an initial offering. The most interesting thing about Archemix is that it’s th... |
| Healthcare startup with noninvasive, one-time wet AMD treatment touts two years of success | Oraya Therapeutics, one of California’s many healthcare startups, has distinguished itself from the crowd. The medical device company recently presented results from a two-year study showing its IRay, a low-voltage, stereotactic, radiosurgi... | |
| Startup’s device uses targeted radiation – brachytherapy – to treat macular degeneration | One of the most commonly prescribed drugs for wet age-related macular degeneration is Avastin – a cancer drug. So it’s not that surprising that a new approach for wet AMD is radiation therapy – with aims to halt the growth of the unruly blo... |
Reviews 0
FAQ about Lucentis
What has the press written about Lucentis?
Parsers VC has collected 5 articles mentioning Lucentis, among them “Healthcare startup with noninvasive, one-time wet AMD treatment touts two years of success” (Nov 4, 2013) and “Aptamer-drug maker Archemix files for $69M IPO” (Jul 25, 2007).
Is Lucentis still active?
Yes, Lucentis is active; its latest activity on Parsers VC dates from Mar 24, 2015.